Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...
When you think of brain stimulating medtech, startups building wearables as therapeutics probably aren't the first thing that ...
PBMs are putting weight loss drugs, including Wegovy and Zepbound, on their national formularies, but coverage by plans is ...
The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...
There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.
One main concern is to what extent insurance providers will cover such a drug, given the abundance of cheaper alternatives. The FDA has already approved more than a dozen antipsychotics for ...
Initially used to combat recurring Clostridium difficile (C. diff) infections, FMT boasts a success rate of over 90 per cent.
The prescription drug has been all over the news in the past couple of years - but the name Ozempic has become something of a ...
These drugs work similarly but differ in dosage and specific indications (uses). Research suggests that tirzepatide is more ...
The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...
WW stock popped after announcing a new compounded semaglutide product to benefit from the current shortage of weight loss ...
Authorizing Medicare to cover weight loss drugs would increase federal spending by about $35 billion from 2026 to 2034 ...